CellaVision AB develops and markets products for the health care sector, enabling fast and firm blood cell analysis and quality assurance of morphology diagnosis.

The company has cutting-edge expertise within sophisticated digital image analysis, artificial intelligence and automated microscopy. For laboratories, this means increased efficiency, a simplification of the procedures and confirmed proficiency.

The product line includes systems for automatic blood cell differentials and software for differential proficiency testing and education. The products are sold to hospital laboratories and independent commercial laboratories. Today CellaVision is represented in Europe, North America and to some extent in Asia.